FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Federal Register

FDA Corrects Notice on ANDA Withdrawal

Federal Register notice: FDA corrects a 10/22/2021 notice that announced the withdrawal of 216 ANDAs.

Medical Devices

Device Plan on Womens Health Priorities

CDRH releases its Health of Women Program Strategic Plan that intends to boost related regulatory science, and identify and address current and emergi...

Medical Devices

DTM Stimulation Meaningful Results: Medtronic

Medtronic says its DTM SCS endurance therapy showed meaningful pain relief results in a clinical trial.

CGMP and QS Violations in Sunstar Inspection

FDA warns Schaumburg, IL-based Sunstar Americas about drug CGMP and medical device QS violations at its manufacturing facility.

Human Drugs

Complex Innovative Trial Case Studies

FDA releases three case study summaries from the complex innovative trial design pilot program.

Human Drugs

Catalent Belgium FDA-483

FDA issues the latest FDA-483 from an inspection at the troubled Catalent fill and finish contract manufacturing facility in Brussels, Belgium.

Human Drugs

CGMP Violations at South Koreas Cosmo Bio

FDA warns South Koreas Cosmo Bio about CGMP violations in its production of a misbranded and unapproved over-the-counter acne drug.

Human Drugs

FDA Rejects Levo Therapeutics Carbetocin NDA

FDA issues Levo Therapeutics a complete response letter on its NDA for LV-101 (intranasal carbetocin) as a treatment for hyperphagia, anxiousness, and...

Human Drugs

FDA Extends Review on 2 bluebird Gene Therapies

FDA extends by three months the user fee review action dates on two bluebird bio BLAs for its lentiviral vector gene therapies betibeglogene autotemc...

Medical Devices

Device User Fee Negotiations at Standstill

FDA and the medical device industry are at a standstill in their negotiations on the next five-year iteration of the medical device user fee agreement...